Statement Of Cash Flows [Abstract]

Isofol Medical - Filing #689617

Concept As at
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
As at
2020-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Profit (loss)
- SEK
159 755 SEK
- SEK
159 755 SEK
- SEK
- SEK
200 251 SEK
200 251 SEK
Adjustments to reconcile profit (loss) [abstract]
Adjustments for decrease (increase) in other operating receivables
504,000 SEK
9 860 SEK
Adjustments for increase (decrease) in other operating payables
31 166 SEK
4 907 SEK
Other adjustments for non-cash items
450,000 SEK
2 946 SEK
Income taxes paid (refund), classified as operating activities
- SEK
- SEK
Cash flows from (used in) operating activities
190 975 SEK
188 429 SEK
Cash flows from (used in) investing activities [abstract]
Purchase of property, plant and equipment, classified as investing activities
- SEK
- SEK
Cash flows from (used in) investing activities
- SEK
- SEK
Cash flows from (used in) financing activities [abstract]
Proceeds from issuing shares
- SEK
451 917 SEK
Proceeds from issuing other equity instruments
23,000 SEK
108,000 SEK
Payments of lease liabilities, classified as financing activities
1 704 SEK
1 548 SEK
Cash flows from (used in) financing activities
1 681 SEK
450 477 SEK
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes
192 656 SEK
262 048 SEK
Effect of exchange rate changes on cash and cash equivalents [abstract]
Effect of exchange rate changes on cash and cash equivalents
3 791 SEK
1 007 SEK
Cash and cash equivalents
190 583 SEK
379 448 SEK
116 393 SEK

Talk to a Data Expert

Have a question? We'll get back to you promptly.